Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mastercard
MA
|
+$915M |
| 2 |
Meta Platforms (Facebook)
META
|
+$693M |
| 3 |
Salesforce
CRM
|
+$618M |
| 4 |
Walt Disney
DIS
|
+$559M |
| 5 |
Nike
NKE
|
+$545M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$1.51B |
| 2 |
Pfizer
PFE
|
+$1.43B |
| 3 |
UBS Group
UBS
|
+$588M |
| 4 |
HSBC
HSBC
|
+$537M |
| 5 |
Procter & Gamble
PG
|
+$439M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.07% |
| 2 | Consumer Discretionary | 10.99% |
| 3 | Financials | 10.93% |
| 4 | Healthcare | 10.39% |
| 5 | Communication Services | 6.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
251
UBS Group
UBS
$176B
| $12.8M | 0.02% |
1,387,251
-51,059,052
| -97% | -$588M |
|
252
Vanguard FTSE Emerging Markets ETF
VWO
$124B
| $12.7M | 0.02% |
378,430
+28,745
| +8% | +$1.17M |
|
|
FRC
253
DELISTED
First Republic Bank
FRC
| $12.7M | 0.02% |
154,139
-13,530
| -8% | -$1.43M |
|
254
Gerdau
GGB
$9.7B
| $12.7M | 0.02% |
8,347,550
-1,712,489
| -17% | -$5.43M |
|
255
Webster Financial
WBS
$12.8B
| $12.6M | 0.02% |
550,293
-14,747
| -3% | -$600K |
|
256
Teradyne
TER
$59.3B
| $12.6M | 0.02% |
232,527
-110,087
| -32% | -$6.99M |
|
257
Freshpet
FRPT
$3.22B
| $12.5M | 0.02% |
195,692
+15,995
| +9% | +$1.03M |
|
|
AAWW
258
DELISTED
Atlas Air Worldwide Holdings, Inc.
AAWW
| $12.5M | 0.02% |
485,274
-16,772
| -3% | -$419K |
|
|
PACW
259
DELISTED
PacWest Bancorp
PACW
| $12.3M | 0.02% |
683,778
-18,352
| -3% | -$575K |
|
|
ZEN
260
DELISTED
ZENDESK INC
ZEN
| $12.2M | 0.02% |
190,445
-10,311
| -5% | -$805K |
|
261
Paylocity
PCTY
$7.98B
| $11.9M | 0.01% |
135,076
-16,768
| -11% | -$2.11M |
|
262
Delek US
DK
$3.58B
| $11.9M | 0.01% |
753,176
-82,756
| -10% | -$1.96M |
|
263
Nice
NICE
$5.97B
| $11.8M | 0.01% |
81,928
+130
| +0.2% | +$21K |
|
264
Curtiss-Wright
CW
$25.5B
| $11.6M | 0.01% |
+124,998
| New | +$16M |
|
265
COPT Defense Properties
CDP
$4.21B
| $11.5M | 0.01% |
520,220
-3,599
| -0.7% | -$97.7K |
|
|
AYX
266
DELISTED
Alteryx Inc
AYX
| $11.5M | 0.01% |
120,757
-5,088
| -4% | -$632K |
|
267
Bristol-Myers Squibb
BMY
$132B
| $11.1M | 0.01% |
199,474
-309,852
| -61% | -$18.9M |
|
268
Veeco
VECO
$3.23B
| $11M | 0.01% |
1,153,592
-28,836
| -2% | -$387K |
|
269
Moog Inc Class A
MOG.A
$12.8B
| $11M | 0.01% |
218,144
+200,802
| +1,158% | +$15.6M |
|
270
Northwest Natural Holdings
NWN
$2.12B
| $11M | 0.01% |
177,476
-5,372
| -3% | -$376K |
|
|
NTUS
271
DELISTED
Natus Medical Inc
NTUS
| $10.4M | 0.01% |
450,634
+8,862
| +2% | +$258K |
|
272
ATI
ATI
$31.1B
| $9.98M | 0.01% |
1,174,669
-9,043
| -0.8% | -$144K |
|
273
Cummins
CMI
$88.7B
| $9.91M | 0.01% |
73,262
-2,732
| -4% | -$426K |
|
274
Deere & Co
DE
$168B
| $9.9M | 0.01% |
71,659
-6,322
| -8% | -$1M |
|
275
PepsiCo
PEP
$190B
| $9.83M | 0.01% |
81,864
-65,247
| -44% | -$8.82M |
|
Similar funds
Ken Fisher's Q1 2020 Portfolio in Review
As of Q1 2020, Ken Fisher held 982 positions worth $80.6B, down 19% from $99B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Fisher's Q1 2020 filing shows 84 new, 262 increased, 421 reduced and 116 closed positions. Its largest new stake was Advanced Micro Devices: 7,132,669 shares worth $324M. The largest sale was Johnson & Johnson, an estimated $1.51B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Financials.
- Ken Fisher's largest Q1 2020 buy was Advanced Micro Devices: 7,132,669 shares worth $324M.
- Ken Fisher added most to Mastercard in Q1 2020, an estimated $915M increase.
- Ken Fisher's biggest Q1 2020 reduction was Johnson & Johnson, cutting an estimated $1.51B.
- Ken Fisher fully exited Ambev in Q1 2020, selling an estimated $89.9M.
- Ken Fisher's ten largest holdings make up 31% of its $80.6B portfolio in Q1 2020.
- Ken Fisher opened 84 new positions and closed 116 in Q1 2020.
- Ken Fisher's portfolio value fell 19% quarter-over-quarter to $80.6B.
Based on Fisher Asset Management's 13F filing for Q1 2020, filed 28 Apr 2020.